These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24048103)

  • 1. Successful etanercept desensitization in a patient with severe injection site reactions.
    Hall J; Findeisen J
    J Clin Rheumatol; 2013 Oct; 19(7):407-8. PubMed ID: 24048103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection-site reaction to etanercept: role of skin test in the diagnosis of such reaction and successful desensitization.
    Bavbek S; Aydın O; Ataman S; Cahill K; Castells M
    Allergy; 2011 Sep; 66(9):1256-7. PubMed ID: 21507006
    [No Abstract]   [Full Text] [Related]  

  • 5. Worsening injection site reactions with continued use of etanercept.
    Edwards KR; Mowad CM; Tyler WB
    J Drugs Dermatol; 2003 Apr; 2(2):184-7. PubMed ID: 12852371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parapharyngeal abscess in a patient receiving etanercept.
    Borrás-Blasco J; Nuñez-Cornejo C; Gracia-Perez A; Rosique-Robles JD; Casterá MD; Viosca E; Abad FJ
    Ann Pharmacother; 2007 Feb; 41(2):341-4. PubMed ID: 17227824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
    Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
    J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
    [No Abstract]   [Full Text] [Related]  

  • 8. The medical uses and side effects of etanercept with a focus on cutaneous disease.
    Scheinfeld N
    J Drugs Dermatol; 2004; 3(6):653-9. PubMed ID: 15624748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
    Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA
    Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study.
    Prince FH; Twilt M; Jansen-Wijngaarden NC; van Suijlekom-Smit LW
    Ann Rheum Dis; 2007 May; 66(5):704-5. PubMed ID: 17324973
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary sarcoidosis associated with etanercept therapy.
    Farah RE; Shay MD
    Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritis.
    Bullano MF; McNeeley BJ; Yu YF; Quimbo R; Burawski LP; Yu EB; Woolley JM
    Manag Care Interface; 2006 Sep; 19(9):47-53. PubMed ID: 17017313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept urticaria in a patient with psoriasis desensitized using a new method.
    Fellner MJ; Yohe N
    J Drugs Dermatol; 2013 Oct; 12(10):1168-9. PubMed ID: 24085054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
    Moreland LW; Schiff MH; Baumgartner SW; Tindall EA; Fleischmann RM; Bulpitt KJ; Weaver AL; Keystone EC; Furst DE; Mease PJ; Ruderman EM; Horwitz DA; Arkfeld DG; Garrison L; Burge DJ; Blosch CM; Lange ML; McDonnell ND; Weinblatt ME
    Ann Intern Med; 1999 Mar; 130(6):478-86. PubMed ID: 10075615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recalcitrant hand pompholyx: variable response to etanercept.
    Ogden S; Clayton TH; Goodfield MJ
    Clin Exp Dermatol; 2006 Jan; 31(1):145-6. PubMed ID: 16309517
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment advances in rheumatoid arthritis.
    Arriola ER; Lee NP
    West J Med; 1999 May; 170(5):278-81. PubMed ID: 10379219
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.
    Leonardi C; Strober B; Gottlieb AB; Elewski BE; Ortonne JP; van de Kerkhof P; Chiou CF; Dunn M; Jahreis A
    J Drugs Dermatol; 2010 Aug; 9(8):928-37. PubMed ID: 20684143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.